Literature DB >> 28196297

Targeting invasive properties of melanoma cells.

Imanol Arozarena1, Claudia Wellbrock2.   

Abstract

Melanoma is a skin cancer notorious for its metastatic potential. As an initial step of the metastatic cascade, melanoma cells part from the primary tumour and invade the surrounding tissue, which is crucial for their dissemination and the formation of distant secondary tumours. Over the last two decades, our understanding of both, general and melanoma specific mechanisms of invasion has significantly improved, but to date no efficient therapeutic strategy tackling the invasive properties of melanoma cells has reached the clinic. In this review, we assess the major contributions towards the understanding of the molecular biology of melanoma cell invasion with a focus on melanoma specific traits. These traits are based on the neural crest origin of melanoma cells and explain their intrinsic invasive nature. A particular emphasis is given not only to lineage specific signalling mediated by TGFβ, and noncanonical and canonical WNT signalling, but also to the role of PDE5A and RHO-GTPases in modulating modes of melanoma cell invasion. We discuss existing caveats in the current understanding of the metastatic properties of melanoma cells, as well as the relevance of the 'phenotype switch' model and 'co-operativity' between different phenotypes in heterogeneous tumours. At the centre of these phenotypes is the lineage commitment factor microphthalmia-associated transcription factor, one of the most crucial regulators of the balance between de-differentiation (neural crest specific gene expression) and differentiation (melanocyte specific gene expression) that defines invasive and noninvasive melanoma cell phenotypes. Finally, we provide insight into the current evidence linking resistance to targeted therapies to invasive properties of melanoma cells.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990MITFzzm321990; zzm321990RACzzm321990; zzm321990RHOzzm321990; PDE5A; TGFβ; WNT5A; co-operative invasion; invasion; melanoma; phenotype switching

Mesh:

Substances:

Year:  2017        PMID: 28196297     DOI: 10.1111/febs.14040

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  16 in total

1.  RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

Authors:  Tomasz Radaszkiewicz; Michaela Nosková; Kristína Gömöryová; Olga Vondálová Blanářová; Katarzyna Anna Radaszkiewicz; Markéta Picková; Ráchel Víchová; Tomáš Gybeľ; Karol Kaiser; Lucia Demková; Lucia Kučerová; Tomáš Bárta; David Potěšil; Zbyněk Zdráhal; Karel Souček; Vítězslav Bryja
Journal:  Elife       Date:  2021-10-27       Impact factor: 8.140

2.  Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.

Authors:  Marie R Webster; Mitchell E Fane; Gretchen M Alicea; Subhasree Basu; Andrew V Kossenkov; Gloria E Marino; Stephen M Douglass; Amanpreet Kaur; Brett L Ecker; Keerthana Gnanapradeepan; Abibatou Ndoye; Curtis Kugel; Alexander Valiga; Jessica Palmer; Qin Liu; Xiaowei Xu; Jessicamarie Morris; Xiangfan Yin; Hong Wu; Wei Xu; Cathy Zheng; Giorgos C Karakousis; Ravi K Amaravadi; Tara C Mitchell; Filipe V Almeida; Min Xiao; Vito W Rebecca; Ying-Jie Wang; Lynn M Schuchter; Meenhard Herlyn; Maureen E Murphy; Ashani T Weeraratna
Journal:  Mol Cell       Date:  2019-12-11       Impact factor: 17.970

Review 3.  Phenotype plasticity as enabler of melanoma progression and therapy resistance.

Authors:  Imanol Arozarena; Claudia Wellbrock
Journal:  Nat Rev Cancer       Date:  2019-06-17       Impact factor: 60.716

4.  High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.

Authors:  Tianxiao Xu; Meng Ma; Zhihong Chi; Lu Si; Xinan Sheng; Chuanliang Cui; Jie Dai; Sifan Yu; Junya Yan; Huan Yu; Xiaowen Wu; Huan Tang; Jiayi Yu; Yan Kong; Jun Guo
Journal:  Cancer Sci       Date:  2018-05-11       Impact factor: 6.716

Review 5.  Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment.

Authors:  Angelica Avagliano; Giuseppe Fiume; Alessandra Pelagalli; Gennaro Sanità; Maria Rosaria Ruocco; Stefania Montagnani; Alessandro Arcucci
Journal:  Front Oncol       Date:  2020-05-22       Impact factor: 6.244

Review 6.  Cell Adhesion Molecules in Plasticity and Metastasis.

Authors:  Jessica A Smart; Julia E Oleksak; Edward J Hartsough
Journal:  Mol Cancer Res       Date:  2020-10-01       Impact factor: 6.333

7.  MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.

Authors:  Jacinta L Simmons; Carly J Pierce; Fares Al-Ejeh; Glen M Boyle
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

8.  Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.

Authors:  Zsofia Miskolczi; Michael P Smith; Emily J Rowling; Jennifer Ferguson; Jorge Barriuso; Claudia Wellbrock
Journal:  Oncogene       Date:  2018-03-16       Impact factor: 9.867

9.  Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma.

Authors:  Weinan Guo; Jinyuan Ma; Tianli Pei; Tao Zhao; Sen Guo; Xiuli Yi; Yu Liu; Shiyu Wang; Guannan Zhu; Zhe Jian; Tianwen Gao; Chunying Li; Wenjun Liao; Qiong Shi
Journal:  J Cell Mol Med       Date:  2018-03-14       Impact factor: 5.310

Review 10.  WNT Signaling in Melanoma.

Authors:  Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.